skip to main content

Marian Wolanski

Direct: 416.863.3355
Fax: 416.863.9171

Marian Wolanski is a partner at Belmore Neidrauer LLP.  Marian practices intellectual property litigation, with a focus on pharmaceutical and biotechnology patent disputes and Patented Medicines (Notice of Compliance) proceedings.  Marian has appeared as counsel in the Federal Court and Federal Court of Appeal.  Marian’s practice also includes providing freedom to operate and patent validity opinions.

Marian was called to the Ontario bar in 2008.  While attending law school at the University of Windsor, Marian completed a clerkship at the Provincial Court and was the managing editor of the Windsor Review of Legal and Social Issues.  

Marian also has a technical background in the life sciences area and has co-authored several publications in scientific journals.  Marian earned a B.Sc.H. (Genetics) from the University of Western Ontario.  She also earned a M.Sc. degree and worked as a research associate in the area of molecular biology at the University of Windsor.


  • Called to the Ontario Bar, 2008
  • University of Windsor, LL.B., 2007
  • University of Windsor, M.Sc. (Molecular Biology), 2004
  • University of Western Ontario, B.Sc.H. (Genetics), 2000


  • Legal 500 Canada 2021: Next Generation Partners
  • Who's Who Legal 2020: Canada - Life Sciences
  • LMG Life Sciences 2020 Star
  • LMG Life Sciences Canadian Rising Star 2018


Date Title Type


Date Case Title Expertise
May 05, 2020 2020 FC 593 Janssen Inc. et al v Teva Canada Limited
We successfully represented Janssen in this patent infringement action under the new PMNOC Regulations concerning Janssen’s Invega Sustenna (...


Jul 13, 2018 2018 FC 736 Eli Lilly Canada Inc. et al v. Apotex Inc.
We represented Eli Lilly, Daiichi and Ube in this application relating to a patent covering Eli Lilly’s EFFIENT product.


Apr 10, 2018 Federal Court File Nos. T-598-17 through T-605-17 AbbVie Corporation et al v Samsung Bioepis Co. Ltd.
We represented AbbVie in a series of eight applications under the PMNOC Regulations relating to AbbVie’s blockbuster drug HUMIRA.  The c...


Apr 09, 2018 Federal Court File No. T-1355-17 Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al.
We represented AbbVie in a patent impeachment action brought by Samsung Bioepis in relation to Samsung Bioepis’ biosimilar to AbbVIe’s ...


Dec 09, 2016 2016 FC 1361 Janssen Inc. et al. v. Actavis Pharma Company et al.
We successfully represented Janssen in a patent case relating to the ADHD medication CONCERTA.  The generic company Actavis Pharma had challen...


More Cases


  • Intellectual Property Institute of Canada (IPIC), Member of Editorial Board of the Canadian Intellectual Property Review
  • Canadian Bar Association
  • The Advocates' Society

Marian Wolanski 


Direct: 416.863.3355
Fax: 416.863.9171

Melanie Carman
Direct: 416.863.3382T 416.863.3382

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy